Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.
Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari DE, Kereiakes DJ, Waksman R, Mauri L, Meredith IT, Finn AV, Kim HS, Kubica J, Suryapranata H, Aprami TM, Di Pasquale G, von Birgelen C, Kedhi E. Navarese EP, et al. Among authors: kedhi e. BMJ. 2013 Nov 6;347:f6530. doi: 10.1136/bmj.f6530. BMJ. 2013. PMID: 24196498 Free PMC article.
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials.
Généreux P, Rutledge DR, Palmerini T, Caixeta A, Kedhi E, Hermiller JB, Wang J, Krucoff MW, Jones-McMeans J, Sudhir K, Simonton CA, Serruys PW, Stone GW. Généreux P, et al. Among authors: kedhi e. Circ Cardiovasc Interv. 2015 May;8(5):e001362. doi: 10.1161/CIRCINTERVENTIONS.114.001362. Circ Cardiovasc Interv. 2015. PMID: 25940520 Clinical Trial.
Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus.
Kennedy MW, Kaplan E, Hermanides RS, Fabris E, Hemradj V, Koopmans PC, Dambrink JH, Marcel Gosselink AT, Van't Hof AW, Ottervanger JP, Roolvink V, Remkes WS, van der Sluis A, Suryapranata H, Kedhi E. Kennedy MW, et al. Among authors: kedhi e. Cardiovasc Diabetol. 2016 Jul 19;15:100. doi: 10.1186/s12933-016-0417-2. Cardiovasc Diabetol. 2016. PMID: 27431395 Free PMC article.
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
Camaro C, Damen SA, Brouwer MA, Kedhi E, Lee SW, Verdoia M, Barbieri L, Rognoni A, van T Hof AW, Ligtenberg E, de Boer MJ, Suryapranata H, De Luca G. Camaro C, et al. Among authors: kedhi e. Am Heart J. 2016 Aug;178:37-44. doi: 10.1016/j.ahj.2016.04.016. Epub 2016 Apr 29. Am Heart J. 2016. PMID: 27502850 Clinical Trial.
Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.
Kennedy MW, Hermanides RS, Kaplan E, Hemradj V, Fabris E, Koopmans PC, Dambrink JE, Gosselink AT, Van't Hof AW, Ottervanger JP, Roolvink V, Remkes WS, van der Sluis A, Suryapranata H, Kedhi E. Kennedy MW, et al. Among authors: kedhi e. Am J Cardiol. 2016 Nov 1;118(9):1293-1299. doi: 10.1016/j.amjcard.2016.07.059. Epub 2016 Aug 13. Am J Cardiol. 2016. PMID: 27614852 Free article.
Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) prospective study. Rationale and design.
Kennedy MW, Fabris E, Ijsselmuiden AJ, Nef H, Reith S, Escaned J, Alfonso F, van Royen N, Wojakowski W, Witkowski A, Indolfi C, Ottervanger JP, Suryapranata H, Kedhi E. Kennedy MW, et al. Among authors: kedhi e. Cardiovasc Diabetol. 2016 Oct 10;15(1):144. doi: 10.1186/s12933-016-0464-8. Cardiovasc Diabetol. 2016. PMID: 27724869 Free PMC article.
156 results